Development of chromatographic technologies for the quality control of Traditional Chinese Medicine in the Chinese Pharmacopoeia.

Chinese pharmacopoeia Chromatographic technology Quality control Traditional Chinese medicine

Journal

Journal of pharmaceutical analysis
ISSN: 2214-0883
Titre abrégé: J Pharm Anal
Pays: China
ID NLM: 101579451

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 20 05 2020
revised: 21 11 2020
accepted: 24 11 2020
entrez: 20 5 2021
pubmed: 21 5 2021
medline: 21 5 2021
Statut: ppublish

Résumé

As an important branch of medicine, Traditional Chinese Medicine (TCM) has been applied for the treatment of diseases for thousands of years in China and other countries in East Asia. The Chinese Pharmacopoeia (ChP) is a drug code formulated by the Chinese government, and it includes a special volume for the monographs of TCM, which plays an important role in ensuring the quality of drugs. The use of quality control technology has always been a complex and important factor in TCM. Owing to the chemical diversity of TCM, chromatography technology has been proven to be a comprehensive strategy for the assessment of the overall quality of TCM and has become the main analytical method in the ChP. This article provides an overview of the classical and modern chromatographic technologies applied in the ChP, and summarizes the advantages and disadvantages of each technique in the TCM monographs. In 2020, the new edition of the ChP (the 2020 edition) has been implemented at the end of 2020. This paper also contains a brief introduction about the application of chromatographic technologies in the new edition of the ChP.

Identifiants

pubmed: 34012691
doi: 10.1016/j.jpha.2020.11.008
pii: S2095-1779(20)31083-2
pmc: PMC8116203
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

155-162

Informations de copyright

© 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

J Sep Sci. 2009 May;32(9):1294-301
pubmed: 19399859
Comb Chem High Throughput Screen. 2010 Dec;13(10):943-53
pubmed: 20883190
Zhongguo Zhong Yao Za Zhi. 2019 Jul;44(13):2748-2752
pubmed: 31359686
J Pharm Anal. 2017 Aug;7(4):265-269
pubmed: 29404048
J Sep Sci. 2010 Jun;33(10):1518-27
pubmed: 20155752
J AOAC Int. 2019 May 1;102(3):720-725
pubmed: 30509338
J Pharm Anal. 2020 Feb;10(1):60-69
pubmed: 32123600
J Chromatogr Sci. 2008 Apr;46(4):289-90
pubmed: 18449971
Phytochem Anal. 2017 Mar;28(2):74-86
pubmed: 28146298
J Sep Sci. 2020 Jan;43(1):150-173
pubmed: 31750981
Anal Chim Acta. 2013 Dec 4;804:16-28
pubmed: 24267059
J Sep Sci. 2017 May;40(9):1942-1952
pubmed: 28318104
Zhongguo Zhong Yao Za Zhi. 2014 Feb;39(3):351-6
pubmed: 24946530
J Pharm Biomed Anal. 2020 Jan 30;178:112909
pubmed: 31618702
J Pharm Anal. 2016 Aug;6(4):249-255
pubmed: 29403990
J Sep Sci. 2007 Dec;30(18):3268-95
pubmed: 18069740
J Pharm Biomed Anal. 2010 Aug 1;52(4):452-60
pubmed: 20144519
Biomed Chromatogr. 1998 May-Jun;12(3):133-5
pubmed: 9646911
Phytochem Anal. 2017 Mar;28(2):115-124
pubmed: 28028844

Auteurs

Ming-Rui Shen (MR)

Chinese Pharmacopoeia Commission, No.11 Fahua Nanli, Beijing, 100061, China.

Yi He (Y)

Chinese Pharmacopoeia Commission, No.11 Fahua Nanli, Beijing, 100061, China.

Shang-Mei Shi (SM)

Chinese Pharmacopoeia Commission, No.11 Fahua Nanli, Beijing, 100061, China.

Classifications MeSH